316 related articles for article (PubMed ID: 23353806)
41. Doxorubicin (DOX) Gadolinium-Gold-Complex: A New Way to Tune Hybrid Nanorods as Theranostic Agent.
Khan M; Boumati S; Arib C; Thierno Diallo A; Djaker N; Doan BT; Spadavecchia J
Int J Nanomedicine; 2021; 16():2219-2236. PubMed ID: 33762822
[TBL] [Abstract][Full Text] [Related]
42. Efficient Magnetic Nanocatalyst-Induced Chemo- and Ferroptosis Synergistic Cancer Therapy in Combination with T
Zhu L; Wang J; Tang X; Zhang C; Wang P; Wu L; Gao W; Ding W; Zhang G; Tao X
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3621-3632. PubMed ID: 35005898
[TBL] [Abstract][Full Text] [Related]
43. A Gd3Al tetranuclear complex as a potential bimodal MRI/optical imaging agent.
Li WS; Luo J; Jiang F; Chen ZN
Dalton Trans; 2012 Aug; 41(31):9405-10. PubMed ID: 22740063
[TBL] [Abstract][Full Text] [Related]
44. Graphene oxide based theranostic platform for T1-weighted magnetic resonance imaging and drug delivery.
Zhang M; Cao Y; Chong Y; Ma Y; Zhang H; Deng Z; Hu C; Zhang Z
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13325-32. PubMed ID: 24313343
[TBL] [Abstract][Full Text] [Related]
45. Multifunctional pH-sensitive superparamagnetic iron-oxide nanocomposites for targeted drug delivery and MR imaging.
Zhu L; Wang D; Wei X; Zhu X; Li J; Tu C; Su Y; Wu J; Zhu B; Yan D
J Control Release; 2013 Aug; 169(3):228-38. PubMed ID: 23485450
[TBL] [Abstract][Full Text] [Related]
46. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.
Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY
Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697
[TBL] [Abstract][Full Text] [Related]
47. Single-walled carbon nanotube-loaded doxorubicin and Gd-DTPA for targeted drug delivery and magnetic resonance imaging.
Yan C; Chen C; Hou L; Zhang H; Che Y; Qi Y; Zhang X; Cheng J; Zhang Z
J Drug Target; 2017 Feb; 25(2):163-171. PubMed ID: 27499100
[TBL] [Abstract][Full Text] [Related]
48. Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T1-weighted MR and photoluminescence imaging.
Jung J; Kim MA; Cho JH; Lee SJ; Yang I; Cho J; Kim SK; Lee C; Park JK
Biomaterials; 2012 Aug; 33(24):5865-74. PubMed ID: 22617320
[TBL] [Abstract][Full Text] [Related]
49. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
51. Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy.
Ranney D; Antich P; Dadey E; Mason R; Kulkarni P; Singh O; Chen H; Constantanescu A; Parkey R
J Control Release; 2005 Dec; 109(1-3):222-35. PubMed ID: 16290245
[TBL] [Abstract][Full Text] [Related]
52. Aptamer-Directed Specific Drug Delivery and Magnetic Resonance Imaging of Renal Carcinoma Cells In Vitro and In Vivo.
Li J; Wang J; Sun D; Dai Y; Shen J; You J; Han C; Xu K
J Biomed Nanotechnol; 2016 Aug; 12(8):1604-616. PubMed ID: 29342341
[TBL] [Abstract][Full Text] [Related]
53. ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects.
Ye DX; Ma YY; Zhao W; Cao HM; Kong JL; Xiong HM; Möhwald H
ACS Nano; 2016 Apr; 10(4):4294-300. PubMed ID: 27018822
[TBL] [Abstract][Full Text] [Related]
54. Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release.
Basuki JS; Duong HT; Macmillan A; Erlich RB; Esser L; Akerfeldt MC; Whan RM; Kavallaris M; Boyer C; Davis TP
ACS Nano; 2013 Nov; 7(11):10175-89. PubMed ID: 24131276
[TBL] [Abstract][Full Text] [Related]
55. Multifunctional nanocomposite based on graphene oxide for in vitro hepatocarcinoma diagnosis and treatment.
Shen AJ; Li DL; Cai XJ; Dong CY; Dong HQ; Wen HY; Dai GH; Wang PJ; Li YY
J Biomed Mater Res A; 2012 Sep; 100(9):2499-506. PubMed ID: 22623284
[TBL] [Abstract][Full Text] [Related]
56. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
[TBL] [Abstract][Full Text] [Related]
57. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
Raatschen HJ; Fu Y; Shames DM; Wendland MF; Brasch RC
Invest Radiol; 2006 Dec; 41(12):860-7. PubMed ID: 17099424
[TBL] [Abstract][Full Text] [Related]
58. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
Lee ES; Na K; Bae YH
J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
[TBL] [Abstract][Full Text] [Related]
59. Chitosan oligosaccharide-arachidic acid-based nanoparticles for anti-cancer drug delivery.
Termsarasab U; Cho HJ; Kim DH; Chong S; Chung SJ; Shim CK; Moon HT; Kim DD
Int J Pharm; 2013 Jan; 441(1-2):373-80. PubMed ID: 23174411
[TBL] [Abstract][Full Text] [Related]
60. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
